Clinical Trial Update: Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT

View source ↗

Summary

A completed clinical trial evaluating the use of FPIA PET/CT to measure treatment response in metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Imperial College London | Conditions: Metastatic Renal Cell Carcinoma | Status: COMPLETED